Stocks
Rapid risers (past year)
INTC · Intel CorpHolda year ago$17.97→now$99.17+452%market value$511.4BIntel designs and manufactures computer processor chips used in PCs, servers, and data centers.
why Intel experienced a massive ~453% rally over the past year, as noted directly in the headline 'Intel Just Experienced a Monster 453% Rally. Is It Time to Sell or Double Down?', though the provided headlines do not explain the underlying reason for the surge. source
Analysts are cautiously neutral — the massive run-up is noted but conviction to chase it remains low, with a Hold consensus.
AMD · Advanced Micro Devices IncBuya year ago$105.70→now$466.38+341%market value$771.3BAdvanced Micro Devices makes computer processors and graphics chips for PCs, gaming consoles, and data centers.
why The provided headlines do not explain AMD's ~341% rise; the headlines reference AVGO, broad market moves, and AI innovation ETFs but contain no AMD-specific explanation for the move.
Analysts are broadly bullish — strong Buy consensus suggests the AI-driven momentum is seen as fundamentally justified.
GOOGL · Alphabet IncBuya year ago$166.40→now$368.53+122%market value$4.47TAlphabet runs Google Search, YouTube, and a major cloud computing business.
why Google's stock likely rose in part due to a major $30 billion computing power deal struck with SpaceX, signaling strong AI infrastructure demand and a significant commercial partnership. source
Analysts are very enthusiastic — near-unanimous Buy consensus reflects confidence in its AI integration and advertising recovery.
QCOM · Qualcomm IncHolda year ago$132.69→now$215.94+63%market value$230.7BQualcomm designs wireless chips and licenses mobile technology used in smartphones and connected devices.
why Qualcomm faced headwinds as Nvidia was reported to be moving into Intel and Qualcomm's turf, raising concerns about increased competition in Qualcomm's core markets. source
Analysts are lukewarm despite the strong run — a Hold consensus suggests the market may have already priced in the good news.
AVGO · Broadcom IncBuya year ago$240.40→now$385.73+61%market value$1.88TBroadcom designs semiconductors and software for networking, storage, and wireless communications.
why Broadcom's stock rose over the past year driven by its premium AI-related valuation and analyst expectations of up to 50% further upside, reflecting strong investor interest in its AI and semiconductor business. source
Analysts are firmly bullish — strong Buy consensus backs the view that its AI networking exposure still has room to run.
NVDA · NVIDIA CorpBuya year ago$133.12→now$205.10+54%market value$5.03TNVIDIA makes graphics processing units and AI accelerator chips widely used in data centers and gaming.
why The provided headlines do not contain an NVDA-specific explanation for its ~54% rise; the Intel rally headline mentions Nvidia only in the context of Intel's performance, and no headline directly addresses Nvidia's own annual gain.
Analysts are overwhelmingly bullish — near-unanimous Buy consensus treats it as the defining pick of the AI hardware boom.
AAPL · Apple IncBuya year ago$200.29→now$307.34+54%market value$4.58TApple designs and sells iPhones, Macs, and other consumer devices alongside a growing services business.
why Apple's stock rose toward all-time highs over the past year, with investor excitement building around the anticipated launch of AI-powered Siri features expected to be unveiled at WWDC. source
Analysts lean bullish — solid Buy consensus reflects confidence in its services growth and AI-enhanced product cycle.
MRK · Merck & Co IncBuya year ago$78.61→now$120.79+54%market value$302.3BMerck develops and sells prescription medicines and vaccines, including its blockbuster cancer drug Keytruda.
why The provided headlines focus almost entirely on smaller biotech companies (AGEN, ERAS) and general healthcare seasonality, and do not contain a Merck-specific explanation for its ~54% rise.
Analysts are broadly bullish — Buy consensus points to strong pipeline confidence and durable revenue from key drugs.
JNJ · Johnson & JohnsonBuya year ago$156.31→now$232.77+49%market value$563.6BJohnson and Johnson develops pharmaceuticals and medical devices sold globally.
why The provided headlines do not contain a Johnson & Johnson-specific explanation for its ~49% rise; the most relevant headline merely notes J&J backed an $85M funding round for CereVasc, which is not sufficient to explain a year-long gain of that magnitude.
Analysts lean bullish — Buy consensus reflects optimism around its pharmaceutical pipeline following its consumer health spinoff.
ORCL · Oracle CorpBuya year ago$151.98→now$213.68+41%market value$619.0BOracle provides database software and cloud computing services to businesses worldwide.
why The provided headlines do not contain an Oracle-specific explanation for its ~41% rise; Oracle is mentioned only in a headline about upcoming market events ('SpaceX IPO, Apple, Oracle Loom') without detail on what drove the annual gain.
Analysts are bullish — Buy consensus suggests the market believes its cloud infrastructure build-out is accelerating meaningfully.
Decliners (past year)
ADBE · Adobe IncHolda year ago$402.73→now$251.44-38%market value$101.9BAdobe makes creative and document software including Photoshop, Illustrator, and Acrobat, sold via subscription.
why Adobe fell sharply over the past year amid growing investor fears that generative AI competitors could erode its dominance, compounded by uncertainty around a CEO transition that put the company's AI leadership and growth story in question. source
Analysts are cautious — a Hold consensus reflects concern that AI-native competitors are threatening its core creative franchise.
CRM · Salesforce IncBuya year ago$258.86→now$185.66-28%market value$153.2BSalesforce provides cloud-based software that helps businesses manage customer relationships and sales pipelines.
why Salesforce declined over the past year as major institutional investors such as Bridgewater sold their positions, reflecting broader concerns about the stock's outlook amid a tech sector sell-off. source
Analysts remain broadly bullish despite the decline — Buy consensus suggests the sell-off is seen as overdone given AI opportunity.
COIN · Coinbase Global IncBuya year ago$237.70→now$152.40-36%market value$39.3BCoinbase operates a platform where individuals and institutions can buy, sell, and store cryptocurrencies.
why Coinbase fell sharply as Bitcoin dropped to its lowest level since 2024, retail investors fled crypto, and investors pulled money from Bitcoin ETFs, all of which reduced trading activity and sentiment that drives Coinbase's business. source
Analysts lean bullish on balance — Buy consensus suggests believers see crypto volatility as cyclical rather than structural damage.
META · Meta Platforms IncBuya year ago$650.05→now$593.00-9%market value$1.54TMeta Platforms owns Facebook, Instagram, and WhatsApp and sells advertising across those social networks.
why Meta's stock declined modestly over the past year, with a notable sell-off tied to reports of a large stock sale and investor concerns about rising costs, even as the company pursued new AI-driven ad business strategies. source
Analysts are very bullish despite the pullback — near-unanimous Buy consensus treats the dip as a buying opportunity in a dominant ad platform.
MSFT · Microsoft CorpBuya year ago$451.54→now$416.67-8%market value$3.13TMicrosoft makes Windows, Office productivity software, and Azure cloud services used by businesses globally.
why Microsoft's stock dipped modestly over the past year as rising Fed rate-increase expectations weighed on big tech valuations and broader Nasdaq sell-offs dragged on the stock. source
Analysts are firmly bullish — overwhelming Buy consensus views the modest decline as a temporary pause in a strong AI-driven growth story.
BRK.B · Berkshire Hathaway IncSella year ago$501.31→now$488.13-3%market value$1.05TBerkshire Hathaway is a holding company that owns a diverse range of businesses and a large stock portfolio managed by Warren Buffett.
why The headlines provided do not clearly explain Berkshire Hathaway's modest decline over the past year; they reference a trader buying more BRK.B and unrelated Alphabet news, but nothing directly explains the stock's move.
Analysts are notably bearish — a rare Sell consensus suggests the market sees limited upside relative to peers at current valuations.
Potential (room to grow)
CRM · Salesforce IncBuy3 months ago$189.92→now$185.66-2%market value$152.1BMakes software that helps businesses manage their customer relationships, sales pipelines, and marketing campaigns.
why Salesforce stock fell amid broad tech sector sell-offs, including the Nasdaq's worst day in over a year, and was also pressured by major investors like Bridgewater selling their positions. source
It has held up better than the broader market over three months and carries strong analyst buy support, suggesting investors see its recent pullback as an opportunity rather than a warning sign.
MA · Mastercard IncBuy3 months ago$533.04→now$491.08-8%market value$433.9BRuns the global payment network that processes card transactions between banks, merchants, and consumers worldwide.
why The provided headlines do not explain a decline for Mastercard; they instead highlight positive spending growth across income bands and strategic initiatives, so the source material does not account for the stock's -17.5% move.
It has outperformed the S&P 500 over three months and boasts one of the strongest analyst buy ratios in the entire list, pointing to high confidence in its durable growth.
UNH · UnitedHealth Group IncBuy3 months ago$294.17→now$399.47+36%market value$360.1BProvides health insurance plans and runs a large health services and pharmacy benefits business for millions of Americans.
why UnitedHealth stock rose as investors sought stability in healthcare, with the stock jumping 20% year-to-date and leading a healthcare sector rebound. source
It has delivered strong positive momentum over both one year and three months, beating the S&P by a wide margin, and analysts overwhelmingly rate it a buy.
MRK · Merck & Co IncBuy3 months ago$120.81→now$120.79+0%market value$298.3BDiscovers, makes, and sells prescription medicines, vaccines, and animal health products globally.
why The headlines do not clearly explain Merck's 53.6% rise; one article discusses the market buying into Merck's post-Keytruda pipeline promise, but the sources are largely about other companies and do not provide a definitive explanation. source
It has nearly held flat over three months while the S&P fell meaningfully, effectively outperforming the market, and analysts give it a solid buy consensus.
ABBV · AbbVie IncBuy3 months ago$238.59→now$227.23-5%market value$401.5BDevelops and sells specialty medicines, including treatments for immune diseases, cancer, and neurological conditions.
why AbbVie stock rose, supported by the European Commission's approval of AQUIPTA, adding a regulatory catalyst while the stock outperformed a declining broader market. source
It has outpaced the S&P over three months and carries a heavy analyst buy rating, reflecting confidence in its broad drug portfolio and pipeline.
TMO · Thermo Fisher Scientific IncBuy3 months ago$502.87→now$472.80-6%market value$175.7BSupplies scientific instruments, lab equipment, and research services to pharmaceutical, biotech, and academic customers.
why Thermo Fisher Scientific's bull case was bolstered by AI-enhanced Orbitrap drug discovery product launches, though an HSBC downgrade served as a headwind; the net result was a modest gain. source
It has beaten the S&P over three months and earns a strong buy consensus from analysts, who see it as a reliable backbone of the life sciences industry.
CVX · Chevron CorpBuy3 months ago$185.00→now$187.31+1%market value$373.0BExplores for, produces, and sells oil, natural gas, and refined energy products around the world.
why Chevron stock outpaced its industry peers and was highlighted as an ultra-safe Dow dividend stock, contributing to its strong year-over-year gain. source
It has outperformed the S&P by a healthy margin over three months and holds a firm analyst buy rating, benefiting from sustained energy demand.
COP · ConocoPhillipsBuy3 months ago$113.62→now$117.14+3%market value$142.7BFinds and produces oil and natural gas in the United States and internationally, focused purely on exploration and production.
why The provided headlines do not clearly explain ConocoPhillips' 38.7% rise; the most relevant article notes mixed short-term performance and discusses valuation, but the sources do not provide a definitive explanation for the annual gain. source
It has edged out the S&P over three months and analysts back it with a clear buy majority, reflecting its lean cost structure and strong cash generation.
GE · General Electric CoBuy3 months ago$340.17→now$328.00-4%market value$342.2BMakes jet engines, aviation systems, and power equipment used in aircraft and energy infrastructure worldwide.
why GE Aerospace rose on the strength of its commercial engines unit and growing airline demand for GEnx engines, driving optimism about further upside. source
It has significantly outperformed the S&P over three months and carries a strong analyst buy rating, driven by rising demand for commercial aviation and defense spending.
SMCI · Super Micro Computer IncBuy3 months ago$28.99→now$41.64+44%market value$25.0BDesigns and builds high-performance server systems and data center hardware used in artificial intelligence and cloud computing.
why Super Micro Computer shares were volatile and fell sharply on at least one occasion, with a headline specifically covering why the stock was plummeting, amid broader tech sector sell-offs. source
It has dramatically outpaced the S&P over three months and analysts lean toward buy, reflecting booming demand for AI infrastructure where its products play a central role.
PLTR · Palantir Technologies IncBuy3 months ago$146.52→now$135.53-7%market value$324.9BBuilds data analytics and artificial intelligence software platforms used by governments and large corporations to make sense of complex information.
why Palantir's AI platform strength was cited as a key positive driver, with Wedbush noting its AI edge getting stronger and its Rule of 40 metrics indicating strong AI dominance, though defense budget uncertainty tempered gains. source
Analysts give it a buy majority and its three-month decline was notably smaller than the S&P drop, suggesting the market sees its AI-focused business as relatively resilient.
COST · Costco Wholesale CorpBuy3 months ago$1,006.24→now$971.87-3%market value$431.0BOperates a chain of membership warehouse clubs where shoppers pay an annual fee to buy goods in bulk at low prices.
why The provided headlines do not clearly explain a decline for Costco; in fact, one headline highlights 9.8% same-store sales growth in Q3 2026, so the source material does not account for the stock's -7.5% move.
It has outperformed the S&P over three months and commands a strong analyst buy consensus, as its loyal membership model tends to hold up well even when consumers tighten their belts.
HD · Home Depot IncBuy3 months ago$370.10→now$310.78-16%market value$309.9BSells home improvement products, tools, and building materials through a large chain of warehouse-style retail stores.
why The provided headlines do not clearly explain Home Depot's -16.8% decline; the articles are mostly general market coverage without a specific catalyst for HD's underperformance. source
It has beaten the S&P over three months by a wide margin and analysts back it with a clear buy rating, pointing to long-term upside as housing activity eventually recovers.
NKE · Nike IncBuy3 months ago$57.78→now$42.98-26%market value$63.6BDesigns, markets, and sells athletic footwear, apparel, and sports equipment to consumers around the world.
why The narrative around Nike was evolving without a new price target, suggesting investor uncertainty, while the stock remained under pressure with no clear positive catalyst in the headlines to reverse its decline. source
It has outperformed the S&P over three months despite its recent struggles, and analysts give it a buy consensus, reflecting belief that a brand turnaround is underway.
UBER · Uber Technologies IncBuy3 months ago$75.06→now$70.71-6%market value$146.6BOperates a global app connecting riders with drivers for transportation and customers with restaurants for food delivery.
why Uber stock fell, with one headline specifically asking why it was down 5.9% since its last earnings report, suggesting disappointing post-earnings sentiment weighed on the stock over the year. source
It has outperformed the S&P over three months and enjoys the largest analyst buy pile in the list, reflecting strong conviction that its platform scale leads to lasting profitability.
Not generated yet.